- Home
- PLSE vs ROOT Comparison
PLSE vs ROOT Comparison
Compare PLSE & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- ROOT
- Stock Information
- Founded
- PLSE 2014
- ROOT 2015
- Country
- PLSE United States
- ROOT United States
- Employees
- PLSE N/A
- ROOT N/A
- Industry
- PLSE Medical/Dental Instruments
- ROOT Property-Casualty Insurers
- Sector
- PLSE Health Care
- ROOT Finance
- Exchange
- PLSE Nasdaq
- ROOT Nasdaq
- Market Cap
- PLSE 1.3B
- ROOT 2.3B
- IPO Year
- PLSE 2016
- ROOT 2020
- Fundamental
- Price
- PLSE $18.03
- ROOT $79.08
- Analyst Decision
- PLSE Buy
- ROOT Buy
- Analyst Count
- PLSE 1
- ROOT 6
- Target Price
- PLSE $22.00
- ROOT $124.40
- AVG Volume (30 Days)
- PLSE 169.0K
- ROOT 514.1K
- Earning Date
- PLSE 11-12-2025
- ROOT 11-05-2025
- Dividend Yield
- PLSE N/A
- ROOT N/A
- EPS Growth
- PLSE N/A
- ROOT N/A
- EPS
- PLSE N/A
- ROOT 4.73
- Revenue
- PLSE N/A
- ROOT $1,364,700,000.00
- Revenue This Year
- PLSE N/A
- ROOT $27.41
- Revenue Next Year
- PLSE $700.00
- ROOT $9.74
- P/E Ratio
- PLSE N/A
- ROOT $16.79
- Revenue Growth
- PLSE N/A
- ROOT 59.76
- 52 Week Low
- PLSE $13.77
- ROOT $36.87
- 52 Week High
- PLSE $25.00
- ROOT $181.14
- Technical
- Relative Strength Index (RSI)
- PLSE 53.39
- ROOT 39.22
- Support Level
- PLSE $17.24
- ROOT $74.67
- Resistance Level
- PLSE $18.00
- ROOT $87.50
- Average True Range (ATR)
- PLSE 0.89
- ROOT 4.79
- MACD
- PLSE -0.17
- ROOT -0.43
- Stochastic Oscillator
- PLSE 34.75
- ROOT 25.03
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.